Skip to main content
1005-2016, 1003-2008, 1003-2007
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_492509,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_492509_2017-AHAACC-Focused-Update-for-the-Mgmt-of-Patients-with-Valvular-Heart-Disease.jsp,docTitle=2017 AHA/ACC Focused Update for the Mgmt of Patients with Valvular Heart Disease,xWebsites=professional,dDocAuthor=t-amy.achilles-stefa,xNextReviewDate=09/22/2016 5:42 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=The estimated prevalence of VHD in the United States is 2.5% with no difference between males and females.,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=anticoagulation therapy; aortic stenosis; cardiac surgery; heart valves; mitral regurgitation; prosthetic valves; transcatheter aortic valve replacement; tricuspid stenosis; valvular heart disease,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SMD,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=12/06/2017 5:02 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=12/06/2017 5:02 PM,xWebsiteSection=professional:1463,dDocName=UCM_492509,dpAction=null,dRevLabel=3,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_492509.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=3,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=492509,dIsPrimary=1,dFileSize=15702,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1802874,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=12/06/2017 7:56 PM,xTrashDeleteLoc=null,dCreateDate=12/06/2017 5:02 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=03/15/2017 6:00 PM,xRobotParameter=,xCommunities=1005-2016, 1003-2008, 1003-2007,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

  • VHD prevalence in the United States is 2.5% with no difference between males and females.
  • Valvular heart disease management is rapidly evolving, with advances in diagnostic imaging, and improvements in catheter-based and surgical interventions.
  • This update of the 2014 guidelines on the management of patients with heart valve disease includes changes in indications for:
    • Antibiotic prophylaxis for infective endocarditis (IE)
    • The use of direct oral anticoagulants (DOACs) among patients with atrial fibrillation and heart valve disease 
    • Indications for transcatheter aortic valve replacement (TAVR) 
    • Surgical management of patients with primary and secondary mitral regurgitation (MR)
    • Management of patients with a heart valve prosthesis
Read the full article in Circulation

Related Resources